Joanne M. Donovan, CMO at Edgewise Therapeutics, Inc. (EWTX), sold 42,676 shares at $32.12 ($1.4M) on 2026-03-31, disclosed to the SEC on 2026-03-31.
Scheduled sale ($1.4M) by CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.12 | 21,338 | $685K | 50.0% |
| 2 | $32.12 | 21,338 | $685K | 50.0% |
| Total | $32.12 avg | 42,676 | $1.4M | 100% |
| Filing → |
| EWTX | SELL | 2026-04-02 | $926K | — | Filing → |
| EWTX | SELL | 2026-03-30 | $1.0M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $38K | — | Filing → |